What Abbott Laboratories (ABT)'s First Illinois NEC Verdict Means For Shareholders [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Special Care formula for premature infants was defectively designed and carried inadequate warnings about the risk of necrotizing enterocolitis. This verdict, the first Illinois state court decision in a broader wave of more than 1,700 similar lawsuits, raises material legal and reputational questions for Abbott's nutrition franchise. We'll now examine how this first Illinois NEC verdict, amid extensive ongoing litigation, may influence Abbott's broader investment narrative and risk profile. Outshine the giants: these 19 early-stage AI stocks could fund your retirement Abbott Laboratories Investment Narrative Recap To own Abbott today, you need to believe its diversified devices, diagnostics and nutrition portfolio can offset legal, margin and guidance headwinds. The US$70 million Similac verdict spotlights litigation as a more immediate overhang, but does not appear to alter the near term focus on integrating recent acquisitions, stabilising margins and rebuilding confidenc
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [TheStreet.com]TheStreet.com
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection TestPR Newswire
- Abbott Laboratories (ABT) had its price target lowered by Royal Bank Of Canada from $135.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Sanford C. Bernstein from $125.00 to $110.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website